ModernMedicine Resource Center More Topics


Generic drugs: How to keep those cost savings comingThe U. S. healthcare system saved a record $254 billion from generic drugs in 2014 and $1.68 trillion from 2005 to 2014, but much more can be done.
Any solutions to the sudden price spikes for generics?
Any solutions to the sudden price spikes for generics?A December 9 hearing of the U.S. Senate Special Committee on Aging had senators looking closely at several possible solutions to the recent, massive price spikes for particular generic drugs, including having FDA speed approval for competitors for products with no competition.
Senators target pay-for-delay pharma dealsU.S. Senators Amy Klobuchar (D-Minn.) and Chuck Grassley (R-Iowa) recently reintroduced legislation that would make it illegal for brand-name drug manufacturers to pay-off other drug manufacturers to keep generic versions of brand-name drugs off the market.
Does CVS overcharge some customers for generics?
Does CVS overcharge some customers for generics?That’s the allegation made in a potential class action lawsuit that claims CVS deliberately overcharged some customers for generic drugs by submitting claims to their insurance companies at inflated prices.
FDA approves generic Comtan tablets for Parkinson'sFDA has approved Aurobindo’s entacapone tablets USP, 200 mg, the generic equivalent to Novartis’ Comtan tablets 200 mg.
4 ways the FAST Generics Act will help healthcareRep. Steve Stivers (R-Ohio) and Rep. Peter Welch (D-Vt.) have re-introduced the Fair Access for Safe and Timely (FAST) Generics Act to what they say will increase consumer access to generic drugs, boost market competition and ultimately save consumers money.
FDA moves forward with approval of generic Abilify from 4 different manufacturers despite Otsuka pushbackFDA’s approval of generic versions of Abilify (aripiprazole), an antipsychotic drug approved to treat schizophrenia and bipolar disorder, from 4 different generic manufacturers, has industry insiders pondering the generic drug market.
Amneal buys Actavis’ Australian generics businessAmneal Pharmaceuticals has completed its acquisition of Actavis’ Australian-based generic pharmaceuticals business. Financial terms of the deal were not disclosed.
Generic versions of Abilify approved for mental illness treatmentFour generic manufacturers (Alembic Pharmaceuticals, Hetero Labs, Teva Pharmaceuticals, and Torrent Pharmaceuticals) received the go-ahead April 28 to market their generic versions for Abilify for the treatment of schizophrenia and bipolar disorder.
FDA approves first generic AbilifyThe FDA approved the first generic versions of Abilify (aripiprazole), an antipsychotic drug approved to treat schizophrenia and bipolar disorder, on April 28.